JP2014501232A5 - - Google Patents

Download PDF

Info

Publication number
JP2014501232A5
JP2014501232A5 JP2013543700A JP2013543700A JP2014501232A5 JP 2014501232 A5 JP2014501232 A5 JP 2014501232A5 JP 2013543700 A JP2013543700 A JP 2013543700A JP 2013543700 A JP2013543700 A JP 2013543700A JP 2014501232 A5 JP2014501232 A5 JP 2014501232A5
Authority
JP
Japan
Prior art keywords
phenyl
isopropyl
dihydroxy
triazole
ylmethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013543700A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014501232A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2011/072558 external-priority patent/WO2012084602A1/en
Publication of JP2014501232A publication Critical patent/JP2014501232A/ja
Publication of JP2014501232A5 publication Critical patent/JP2014501232A5/ja
Pending legal-status Critical Current

Links

JP2013543700A 2010-12-20 2011-12-13 抗腫瘍活性を有するアリールトリアゾール化合物 Pending JP2014501232A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10195949.2 2010-12-20
EP10195949 2010-12-20
PCT/EP2011/072558 WO2012084602A1 (en) 2010-12-20 2011-12-13 Aryl triazole compounds with antitumoural activity

Publications (2)

Publication Number Publication Date
JP2014501232A JP2014501232A (ja) 2014-01-20
JP2014501232A5 true JP2014501232A5 (enExample) 2016-01-07

Family

ID=43901588

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013543700A Pending JP2014501232A (ja) 2010-12-20 2011-12-13 抗腫瘍活性を有するアリールトリアゾール化合物

Country Status (16)

Country Link
US (1) US9302998B2 (enExample)
EP (1) EP2655345B1 (enExample)
JP (1) JP2014501232A (enExample)
AR (1) AR084361A1 (enExample)
CY (1) CY1116297T1 (enExample)
DK (1) DK2655345T3 (enExample)
ES (1) ES2536980T3 (enExample)
HR (1) HRP20150450T1 (enExample)
HU (1) HUE025697T2 (enExample)
ME (1) ME02144B (enExample)
PL (1) PL2655345T3 (enExample)
PT (1) PT2655345E (enExample)
RS (1) RS53966B1 (enExample)
SI (1) SI2655345T1 (enExample)
SM (1) SMT201500115B (enExample)
WO (1) WO2012084602A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1206714A1 (en) * 2012-09-17 2016-01-15 霍夫曼-拉罗奇有限公司 Triazole carboxamide derivatives
CN103275023B (zh) * 2013-06-08 2015-10-07 浙江工业大学 1-芳基-1,2,3-三氮唑类化合物及其制备和应用
CN107540624B (zh) * 2016-06-29 2020-06-16 广州市恒诺康医药科技有限公司 热休克蛋白抑制剂及其制备方法和应用
WO2018081814A1 (en) 2016-10-31 2018-05-03 University Of Kansas Grp94 selective inhibitors and uses thereof
WO2019040869A1 (en) * 2017-08-25 2019-02-28 The Trustees Of Columbia University In The City Of New York INHIBITORS OF IMPORTS OF PURINE IN PARASITES AND USES OF THESE INHIBITORS
EP3886854A4 (en) 2018-11-30 2022-07-06 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof
CN110590686B (zh) * 2019-10-31 2022-10-25 重庆大学 一种氮杂糖基1,2,3-三氮唑核苷化合物及其制备方法和应用
WO2021137665A1 (ko) * 2019-12-30 2021-07-08 이화여자대학교 산학협력단 Hsp90 억제제로서의 1,2,3-트리아졸 유도체 화합물 및 이의 용도

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10315570A1 (de) 2003-04-05 2004-10-14 Merck Patent Gmbh Triazolderivate
GB0315111D0 (en) 2003-06-27 2003-07-30 Cancer Rec Tech Ltd Substituted 5-membered ring compounds and their use
GB0323810D0 (en) 2003-10-10 2003-11-12 Cancer Rec Tech Ltd Pyridothiophene compounds
EP2298748B1 (en) 2004-11-18 2016-07-20 Synta Pharmaceuticals Corp. Triazole compounds that modulate HSP90 activity
JPWO2006109846A1 (ja) 2005-04-06 2008-11-20 武田薬品工業株式会社 トリアゾール誘導体およびその用途
JP2006306755A (ja) * 2005-04-27 2006-11-09 Nippon Kayaku Co Ltd 新規なピラゾール誘導体とそれを有効成分とするhsp90阻害剤
AU2006272652B2 (en) * 2005-07-25 2011-06-16 Synta Pharmaceuticals Corp. 1,2,3-triazoles inhibitors of tubulin polymerization for the treatment of proliferative disorders
WO2008041610A1 (fr) * 2006-10-03 2008-04-10 Nippon Kayaku Kabushiki Kaisha Mélange d'un dérivé de résorcinol avec un polymère
CN101679319B (zh) * 2007-02-08 2014-07-09 辛塔医药品有限公司 用于治疗增生性病症如癌症的三唑类化合物
JP2011515359A (ja) 2008-03-18 2011-05-19 グラクソ グループ リミテッド 治療用トリアゾールアミド誘導体
LT5623B (lt) 2008-04-30 2010-01-25 Biotechnologijos Institutas, , 5-aril-4-(5-pakeistieji 2,4-dihidroksifenil)-1,2,3-tiadiazolai kaip hsp90 šaperono slopikliai ir tarpiniai junginiai jiems gauti
US9156836B2 (en) 2008-05-16 2015-10-13 Synta Pharmaceuticals Corp. Tricyclic triazole compounds that modulate HSP90 activity
EP2323737A2 (en) 2008-08-08 2011-05-25 Synta Pharmaceuticals Corp. Triazole compounds that modulate hsp90 activity
ES2415234T3 (es) 2008-08-08 2013-07-24 Synta Pharmaceuticals Corp. Compuestos de triazol que modulan la actividad Hsp90

Similar Documents

Publication Publication Date Title
ME02144B (me) Jedinjenja aril triazola sa antitumorskom aktivnošću
AU2017351688B2 (en) 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH
RU2361860C2 (ru) Новые замещенные 3-сера-индолы
ES2536191T3 (es) Derivados de sulfonamida
JP2016503009A5 (enExample)
CN101622245B (zh) 杀真菌酰胺
JP2009507080A5 (enExample)
JP2014511869A5 (enExample)
JP6605020B2 (ja) Nr2b受容体阻害剤としてのトリアゾール
JP2018503661A5 (enExample)
EA010132B1 (ru) Производные триазола в качестве антагонистов вазопрессина
JP2018502912A5 (enExample)
JP2015529192A5 (enExample)
EP3464248A1 (en) 3-oxo-2,6-diphenyl-2,3-dihydropyridazine-4-carboxamides
JP2007039461A5 (enExample)
JP2017214387A5 (enExample)
JP2013519680A5 (enExample)
JP2014528464A5 (enExample)
JP2017524026A5 (enExample)
JP2008517976A5 (enExample)
JP2017524019A5 (enExample)
JP2016530322A5 (enExample)
RU2348628C2 (ru) Замещенные циклопропильной группой оксазолидиноновые антибиотики и их производные
HRP20220327T1 (hr) Supstituirani triazoli i postupci koji se na njih odnose
AU2006272652B2 (en) 1,2,3-triazoles inhibitors of tubulin polymerization for the treatment of proliferative disorders